{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:51:12Z","timestamp":1787619072756,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Intramural Program NIDDK\/NICHD"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12020-020-02576-y","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T19:02:47Z","timestamp":1610996567000},"page":"96-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Insulin sensitivity and pancreatic \u03b2-cell function in patients with primary aldosteronism"],"prefix":"10.1007","volume":"72","author":[{"given":"Shivraj","family":"Grewal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andin","family":"Fosam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Chalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Deven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Rafael","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny E.","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Paul","family":"Demidowich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranganath","family":"Muniyappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"issue":"4","key":"2576_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.suc.2019.04.010","volume":"99","author":"FT Lee","year":"2019","unstructured":"F.T. Lee, D. Elaraj, Evaluation and management of primary hyperaldosteronism. Surg. Clin. North Am. 99(4), 731\u2013745 (2019). https:\/\/doi.org\/10.1016\/j.suc.2019.04.010","journal-title":"Surg. Clin. North Am."},{"issue":"9","key":"2576_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11886-019-1185-x","volume":"21","author":"GL Hundemer","year":"2019","unstructured":"G.L. Hundemer, Primary aldosteronism: cardiovascular outcomes pre- and post-treatment. Curr. Cardiol. Rep. 21(9), 93 (2019). https:\/\/doi.org\/10.1007\/s11886-019-1185-x","journal-title":"Curr. Cardiol. Rep."},{"issue":"21","key":"2576_CR3","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1056\/NEJM196511182732106","volume":"273","author":"JW Conn","year":"1965","unstructured":"J.W. Conn, Hypertension, the potassium ion and impaired carbohydrate tolerance. N. Engl. J. Med. 273(21), 1135\u20131143 (1965). https:\/\/doi.org\/10.1056\/NEJM196511182732106","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"2576_CR4","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1210\/jc.2012-3934","volume":"98","author":"E Fischer","year":"2013","unstructured":"E. Fischer, C. Adolf, A. Pallauf, C. Then, M. Bidlingmaier, F. Beuschlein, J. Seissler, M. Reincke, Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. J. Clin. Endocrinol. Metab. 98(6), 2513\u20132520 (2013). https:\/\/doi.org\/10.1210\/jc.2012-3934","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"2576_CR5","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1210\/jc.2006-0736","volume":"91","author":"C Catena","year":"2006","unstructured":"C. Catena, R. Lapenna, S. Baroselli, E. Nadalini, G. Colussi, M. Novello, G. Favret, A. Melis, A. Cavarape, L.A. Sechi, Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J. Clin. Endocrinol. Metab. 91(9), 3457\u20133463 (2006). https:\/\/doi.org\/10.1210\/jc.2006-0736","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2576_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1210\/jc.2005-1733","volume":"91","author":"F Fallo","year":"2006","unstructured":"F. Fallo, F. Veglio, C. Bertello, N. Sonino, P. Della Mea, M. Ermani, F. Rabbia, G. Federspil, P. Mulatero, Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J. Clin. Endocrinol. Metab. 91(2), 454\u2013459 (2006). https:\/\/doi.org\/10.1210\/jc.2005-1733","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2576_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1210\/er.2007-0030","volume":"29","author":"JM Connell","year":"2008","unstructured":"J.M. Connell, S.M. MacKenzie, E.M. Freel, R. Fraser, E. Davies, A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr. Rev. 29(2), 133\u2013154 (2008). https:\/\/doi.org\/10.1210\/er.2007-0030","journal-title":"Endocr. Rev."},{"issue":"1","key":"2576_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","volume":"25","author":"G Giacchetti","year":"2007","unstructured":"G. Giacchetti, V. Ronconi, F. Turchi, L. Agostinelli, F. Mantero, S. Rilli, M. Boscaro, Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J. Hypertens. 25(1), 177\u2013186 (2007). https:\/\/doi.org\/10.1097\/HJH.0b013e3280108e6f","journal-title":"J. Hypertens."},{"key":"2576_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.steroids.2014.08.016","volume":"91","author":"JM Luther","year":"2014","unstructured":"J.M. Luther, Effects of aldosterone on insulin sensitivity and secretion. Steroids 91, 54\u201360 (2014). https:\/\/doi.org\/10.1016\/j.steroids.2014.08.016","journal-title":"Steroids"},{"issue":"2","key":"2576_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.numecd.2009.03.007","volume":"20","author":"V Ronconi","year":"2010","unstructured":"V. Ronconi, F. Turchi, S. Rilli, D. Di Mattia, L. Agostinelli, M. Boscaro, G: Giacchetti, Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants. Nutr. Metab. Cardiovasc. Dis. 20(2), 93\u2013100 (2010). https:\/\/doi.org\/10.1016\/j.numecd.2009.03.007","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"12","key":"2576_CR11","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.bbadis.2010.08.005","volume":"1802","author":"JW Funder","year":"2010","unstructured":"J.W. Funder, M. Reincke, Aldosterone: a cardiovascular risk factor? Biochim. Biophys. Acta 1802(12), 1188\u20131192 (2010). https:\/\/doi.org\/10.1016\/j.bbadis.2010.08.005","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"2576_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/jhh.2010.65","volume":"24","author":"Z Somloova","year":"2010","unstructured":"Z. Somloova, J. Widimsky Jr., J. Rosa, D. Wichterle, B. Strauch, O. Petrak, T. Zelinka, J. Vlkova, M. Masek, J. Dvorakova, R. Holaj, The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. J. Hum. Hypertens. 24(10), 625\u2013630 (2010). https:\/\/doi.org\/10.1038\/jhh.2010.65","journal-title":"J. Hum. Hypertens."},{"issue":"9","key":"2576_CR13","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.2337\/dc07-0525","volume":"30","author":"G Colussi","year":"2007","unstructured":"G. Colussi, C. Catena, R. Lapenna, E. Nadalini, A. Chiuch, L.A. Sechi, Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care 30(9), 2349\u20132354 (2007). https:\/\/doi.org\/10.2337\/dc07-0525","journal-title":"Diabetes Care"},{"issue":"1","key":"2576_CR14","doi-asserted-by":"publisher","first-page":"E110","DOI":"10.1152\/ajpendo.00258.2007","volume":"295","author":"G Lastra","year":"2008","unstructured":"G. Lastra, A. Whaley-Connell, C. Manrique, J. Habibi, A.A. Gutweiler, L. Appesh, M.R. Hayden, Y.Z. Wei, C. Ferrario, J.R. Sowers, Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat. Am. J. Physiol. Endocrinol. Metab. 295(1), E110\u2013E116 (2008). https:\/\/doi.org\/10.1152\/ajpendo.00258.2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1-2","key":"2576_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11010-012-1452-2","volume":"372","author":"J Selvaraj","year":"2013","unstructured":"J. Selvaraj, S. Sathish, C. Mayilvanan, K. Balasubramanian, Excess aldosterone-induced changes in insulin signaling molecules and glucose oxidation in gastrocnemius muscle of adult male rat. Mol. Cell Biochem. 372(1-2), 113\u2013126 (2013). https:\/\/doi.org\/10.1007\/s11010-012-1452-2","journal-title":"Mol. Cell Biochem."},{"issue":"8","key":"2576_CR16","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1210\/jc.2010-0097","volume":"95","author":"R Urbanet","year":"2010","unstructured":"R. Urbanet, C. Pilon, A. Calcagno, A. Peschechera, E.L. Hubert, G. Giacchetti, C. Gomez-Sanchez, P. Mulatero, M. Toffanin, N. Sonino, M.C. Zennaro, F. Giorgino, R. Vettor, F. Fallo, Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism. J. Clin. Endocrinol. Metab. 95(8), 4037\u20134042 (2010). https:\/\/doi.org\/10.1210\/jc.2010-0097","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2576_CR17","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1210\/en.2009-0869","volume":"151","author":"T Wada","year":"2010","unstructured":"T. Wada, H. Kenmochi, Y. Miyashita, M. Sasaki, M. Ojima, M. Sasahara, D. Koya, H. Tsuneki, T. Sasaoka, Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. Endocrinology 151(5), 2040\u20132049 (2010). https:\/\/doi.org\/10.1210\/en.2009-0869","journal-title":"Endocrinology"},{"issue":"1-2","key":"2576_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cca.2009.06.030","volume":"407","author":"J Selvaraj","year":"2009","unstructured":"J. Selvaraj, T. Muthusamy, C. Srinivasan, K. Balasubramanian, Impact of excess aldosterone on glucose homeostasis in adult male rat. Clin. Chim. Acta 407(1-2), 51\u201357 (2009). https:\/\/doi.org\/10.1016\/j.cca.2009.06.030","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"2576_CR19","first-page":"21","volume":"108","author":"G Sindelka","year":"2000","unstructured":"G. Sindelka, J. Widimsky, T. Haas, M. Prazny, J. Hilgertova, J. Skrha, Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment. Exp. Clin. Endocr. Diabetes 108(1), 21\u201325 (2000)","journal-title":"Exp. Clin. Endocr. Diabetes"},{"issue":"2","key":"2576_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11845-013-1007-x","volume":"183","author":"W Chen","year":"2014","unstructured":"W. Chen, F. Li, C. He, Y. Zhu, W. Tan, Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis. Ir. J. Med Sci. 183(2), 283\u2013291 (2014). https:\/\/doi.org\/10.1007\/s11845-013-1007-x","journal-title":"Ir. J. Med Sci."},{"issue":"7","key":"2576_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/10641963.2016.1182176","volume":"38","author":"D Watanabe","year":"2016","unstructured":"D. Watanabe, M. Yatabe, A. Ichihara, Evaluation of insulin sensitivity and secretion in primary aldosteronism. Clin. Exp. Hypertens. 38(7), 613\u2013617 (2016). https:\/\/doi.org\/10.1080\/10641963.2016.1182176","journal-title":"Clin. Exp. Hypertens."},{"issue":"10","key":"2576_CR22","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1097\/HJH.0b013e3282861fa4","volume":"25","author":"LM Mosso","year":"2007","unstructured":"L.M. Mosso, C.A. Carvajal, A. Maiz, E.H. Ortiz, C.R. Castillo, R.A. Artigas, C.E. Fardella, A possible association between primary aldosteronism and a lower beta-cell function. J. Hypertens. 25(10), 2125\u20132130 (2007). https:\/\/doi.org\/10.1097\/HJH.0b013e3282861fa4","journal-title":"J. Hypertens."},{"issue":"6","key":"2576_CR23","first-page":"603","volume":"50","author":"J Widimsky","year":"2001","unstructured":"J. Widimsky, B. Strauch, G. Sindelka, J. Skrha, Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus? Physiol. Res. 50(6), 603\u2013607 (2001)","journal-title":"Physiol. Res."},{"issue":"4","key":"2576_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2265.1994.tb02573.x","volume":"41","author":"M Ishimori","year":"1994","unstructured":"M. Ishimori, N. Takeda, S. Okumura, T. Murai, H. Inouye, K. Yasuda, Increased insulin sensitivity in patients with aldosterone producing adenoma. Clin. Endocrinol. 41(4), 433\u2013438 (1994). https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb02573.x","journal-title":"Clin. Endocrinol."},{"issue":"11","key":"2576_CR25","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/0026-0495(92)90019-7","volume":"41","author":"LA Sechi","year":"1992","unstructured":"L.A. Sechi, A. Melis, R. Tedde, Insulin hypersecretion: a distinctive feature between essential and secondary hypertension. Metabolism 41(11), 1261\u20131266 (1992). https:\/\/doi.org\/10.1016\/0026-0495(92)90019-7","journal-title":"Metabolism"},{"issue":"6","key":"2576_CR26","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1210\/jc.2003-030087","volume":"88","author":"GM Reaven","year":"2003","unstructured":"G.M. Reaven, Insulin resistance\/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J. Clin. Endocrinol. Metab. 88(6), 2399\u20132403 (2003). https:\/\/doi.org\/10.1210\/jc.2003-030087","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2576_CR27","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young Jr, The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(5), 1889\u20131916 (2016). https:\/\/doi.org\/10.1210\/jc.2015-4061","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2576_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1109\/10.995680","volume":"49","author":"C Dalla Man","year":"2002","unstructured":"C. Dalla Man, A. Caumo, C. Cobelli, The oral glucose minimal model: estimation of insulin sensitivity from a meal test. IEEE Trans. Biomed. Eng. 49(5), 419\u2013429 (2002). https:\/\/doi.org\/10.1109\/10.995680","journal-title":"IEEE Trans. Biomed. Eng."},{"issue":"11","key":"2576_CR29","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1210\/jcem.85.11.6982","volume":"85","author":"A Caumo","year":"2000","unstructured":"A. Caumo, R.N. Bergman, C. Cobelli, Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index. J. Clin. Endocrinol. Metab. 85(11), 4396\u20134402 (2000). https:\/\/doi.org\/10.1210\/jcem.85.11.6982","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"2576_CR30","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jc.85.7.2402","volume":"85","author":"A Katz","year":"2000","unstructured":"A. Katz, S.S. Nambi, K. Mather, A.D. Baron, D.A. Follmann, G. Sullivan, M.J. Quon, Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocr. Metab. 85(7), 2402\u20132410 (2000). https:\/\/doi.org\/10.1210\/jc.85.7.2402","journal-title":"J. Clin. Endocr. Metab."},{"issue":"9","key":"2576_CR31","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"M. Matsuda, R.A. DeFronzo, Insulin sensitivity indices obtained from oral glucose tolerance testing - Comparison with the euglycemic insulin clamp. Diabetes Care 22(9), 1462\u20131470 (1999). https:\/\/doi.org\/10.2337\/diacare.22.9.1462","journal-title":"Diabetes Care"},{"issue":"1","key":"2576_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1210\/js.2018-00206","volume":"3","author":"R Muniyappa","year":"2019","unstructured":"R. Muniyappa, S.H. Tella, S. Sortur, R. Mszar, S. Grewal, B.S. Abel, S. Auh, D.C. Chang, J. Krakoff, M.C. Skarulis, Predictive accuracy of surrogate indices for hepatic and skeletal muscle insulin sensitivity. J. Endocr. Soc. 3(1), 108\u2013118 (2019). https:\/\/doi.org\/10.1210\/js.2018-00206","journal-title":"J. Endocr. Soc."},{"issue":"1","key":"2576_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2337\/dc06-1519","volume":"30","author":"MA Abdul-Ghani","year":"2007","unstructured":"M.A. Abdul-Ghani, M. Matsuda, B. Balas, R.A. DeFronzo, Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30(1), 89\u201394 (2007). https:\/\/doi.org\/10.2337\/dc06-1519","journal-title":"Diabetes Care"},{"issue":"7","key":"2576_CR34","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2337\/dc09-0729","volume":"32","author":"KM Utzschneider","year":"2009","unstructured":"K.M. Utzschneider, R.L. Prigeon, M.V. Faulenbach, J. Tong, D.B. Carr, E.J. Boyko, D.L. Leonetti, M.J. McNeely, W.Y. Fujimoto, S.E. Kahn, Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 32(7), 1355\u20131355 (2009)","journal-title":"Diabetes Care"},{"issue":"2","key":"2576_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s13105-015-0458-0","volume":"72","author":"JL Santos","year":"2016","unstructured":"J.L. Santos, I. Yevenes, L.R. Cataldo, M. Morales, J. Galgani, C. Arancibia, J. Vega, P. Olmos, M. Flores, J.P. Valderas, F. Pollak, Development and assessment of the disposition index based on the oral glucose tolerance test in subjects with different glycaemic status. J. Physiol. Biochem. 72(2), 121\u2013131 (2016). https:\/\/doi.org\/10.1007\/s13105-015-0458-0","journal-title":"J. Physiol. Biochem."},{"issue":"1","key":"2576_CR36","doi-asserted-by":"publisher","first-page":"R211","DOI":"10.1152\/ajpregu.91000.2008","volume":"298","author":"JF Ndisang","year":"2010","unstructured":"J.F. Ndisang, A. Jadhav, The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298(1), R211\u2013R223 (2010). https:\/\/doi.org\/10.1152\/ajpregu.91000.2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"2","key":"2576_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF00456122","volume":"29","author":"J Pierluissi","year":"1986","unstructured":"J. Pierluissi, F.O. Navas, S.J. Ashcroft, Effect of adrenal steroids on insulin release from cultured rat islets of Langerhans. Diabetologia 29(2), 119\u2013121 (1986). https:\/\/doi.org\/10.1007\/BF00456122","journal-title":"Diabetologia"},{"issue":"12","key":"2576_CR38","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2337\/diab.23.12.933","volume":"23","author":"JC Henquin","year":"1974","unstructured":"J.C. Henquin, A.E. Lambert, Cationic environment and dynamics of insulin secretion. II Effect of a high concentration of potassium. Diabetes 23(12), 933\u2013942 (1974). https:\/\/doi.org\/10.2337\/diab.23.12.933","journal-title":"Diabetes"},{"issue":"8","key":"2576_CR39","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1007\/s00125-011-2158-9","volume":"54","author":"JM Luther","year":"2011","unstructured":"J.M. Luther, P. Luo, M.T. Kreger, M. Brissova, C. Dai, T.T. Whitfield, H.S. Kim, D.H. Wasserman, A.C. Powers, N.J. Brown, Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. Diabetologia 54(8), 2152\u20132163 (2011). https:\/\/doi.org\/10.1007\/s00125-011-2158-9","journal-title":"Diabetologia"},{"issue":"11","key":"2576_CR40","doi-asserted-by":"publisher","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","volume":"150","author":"JR Sowers","year":"2009","unstructured":"J.R. Sowers, A. Whaley-Connell, M. Epstein, Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann. Intern. Med. 150(11), 776\u2013783 (2009). https:\/\/doi.org\/10.7326\/0003-4819-150-11-200906020-00005","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"2576_CR41","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00125-009-1313-z","volume":"52","author":"EJ Barrett","year":"2009","unstructured":"E.J. Barrett, E.M. Eggleston, A.C. Inyard, H. Wang, G. Li, W. Chai, Z. Liu, The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia 52(5), 752\u2013764 (2009). https:\/\/doi.org\/10.1007\/s00125-009-1313-z","journal-title":"Diabetologia"},{"issue":"5","key":"2576_CR42","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1210\/jc.2009-2204","volume":"95","author":"G Iacobellis","year":"2010","unstructured":"G. Iacobellis, L. Petramala, D. Cotesta, M. Pergolini, L. Zinnamosca, R. Cianci, G. De Toma, S. Sciomer, C: Letizia, Adipokines and cardiometabolic profile in primary hyperaldosteronism. J. Clin. Endocrinol. Metab. 95(5), 2391\u20132398 (2010). https:\/\/doi.org\/10.1210\/jc.2009-2204","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2576_CR43","doi-asserted-by":"publisher","first-page":"E101","DOI":"10.1210\/jc.2014-2274","volume":"100","author":"C Letizia","year":"2015","unstructured":"C. Letizia, L. Petramala, C.R. Di Gioia, C. Chiappetta, L. Zinnamosca, C. Marinelli, G. Iannucci, A. Ciardi, G. De Toma, G. Iacobellis, Leptin and adiponectin mRNA expression from the adipose tissue surrounding the adrenal neoplasia. J. Clin. Endocrinol. Metab. 100(1), E101\u2013E104 (2015). https:\/\/doi.org\/10.1210\/jc.2014-2274","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2576_CR44","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.amjhyper.2005.08.019","volume":"19","author":"J Irita","year":"2006","unstructured":"J. Irita, T. Okura, S. Manabe, M. Kurata, K. Miyoshi, S. Watanabe, T. Fukuoka, J. Higaki, Plasma osteopontin levels are higher in patients with primary aldosteronism than in patients with essential hypertension. Am. J. Hypertens. 19(3), 293\u2013297 (2006). https:\/\/doi.org\/10.1016\/j.amjhyper.2005.08.019","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"2576_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","volume":"25","author":"G Giacchetti","year":"2007","unstructured":"G. Giacchetti, V. Ronconi, F. Turchi, L. Agostinelli, F. Mantero, S. Rilli, M. Boscaro, Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J. Hypertens. 25(1), 177\u2013186 (2007). https:\/\/doi.org\/10.1097\/HJH.0b013e3280108e6f","journal-title":"J. Hypertens."},{"issue":"10","key":"2576_CR46","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1097\/HJH.0000000000000284","volume":"32","author":"L Petramala","year":"2014","unstructured":"L. Petramala, P. Pignatelli, R. Carnevale, L. Zinnamosca, C. Marinelli, A. Settevendemmie, A. Concistre, G. Tonnarini, G. De Toma, F. Violi, C. Letizia, Oxidative stress in patients affected by primary aldosteronism. J. Hypertens. 32(10), 2022\u20132029 (2014). https:\/\/doi.org\/10.1097\/HJH.0000000000000284. discussion 2029","journal-title":"J. Hypertens."},{"issue":"2","key":"2576_CR47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1507\/endocrj.51.243","volume":"51","author":"R Yamashita","year":"2004","unstructured":"R. Yamashita, T. Kikuchi, Y. Mori, K. Aoki, Y. Kaburagi, K. Yasuda, H. Sekihara, Aldosterone stimulates gene expression of hepatic gluconeogenic enzymes through the glucocorticoid receptor in a manner independent of the protein kinase B cascade. Endocr. J. 51(2), 243\u2013251 (2004). https:\/\/doi.org\/10.1507\/endocrj.51.243","journal-title":"Endocr. J."},{"issue":"4","key":"2576_CR48","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.bbrc.2006.02.065","volume":"342","author":"G Liu","year":"2006","unstructured":"G. Liu, M. Grifman, B. Keily, J.E. Chatterton, F.W. Staal, Q.X. Li, Mineralocorticoid receptor is involved in the regulation of genes responsible for hepatic glucose production. Biochem. Biophys. Res. Commun. 342(4), 1291\u20131296 (2006). https:\/\/doi.org\/10.1016\/j.bbrc.2006.02.065","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"2576_CR49","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/0026-0495(80)90074-8","volume":"29","author":"JW Rowe","year":"1980","unstructured":"J.W. Rowe, J.D. Tobin, R.M. Rosa, R. Andres, Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 29(6), 498\u2013502 (1980). https:\/\/doi.org\/10.1016\/0026-0495(80)90074-8","journal-title":"Metabolism"},{"issue":"8","key":"2576_CR50","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.amjhyper.2007.03.012","volume":"20","author":"F Fallo","year":"2007","unstructured":"F. Fallo, P. Della Mea, N. Sonino, C. Bertello, M. Ermani, R. Vettor, F. Veglio, P. Mulatero, Adiponectin and insulin sensitivity in primary aldosteronism. Am. J. Hypertens. 20(8), 855\u2013861 (2007). https:\/\/doi.org\/10.1016\/j.amjhyper.2007.03.012","journal-title":"Am. J. Hypertens."},{"issue":"4","key":"2576_CR51","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2337\/db13-1198","volume":"63","author":"C Cobelli","year":"2014","unstructured":"C. Cobelli, C. Dalla Man, G. Toffolo, R. Basu, A. Vella, R. Rizza, The oral minimal model method. Diabetes 63(4), 1203\u20131213 (2014). https:\/\/doi.org\/10.2337\/db13-1198","journal-title":"Diabetes"},{"issue":"5","key":"2576_CR52","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.119.13922","volume":"75","author":"GK Adler","year":"2020","unstructured":"G.K. Adler, G.R. Murray, A.F. Turcu, H. Nian, C. Yu, C.C. Solorzano, R. Manning, D. Peng, J.M. Luther, Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans. Hypertension 75(5), 1251\u20131259 (2020). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.13922","journal-title":"Hypertension"},{"key":"2576_CR53","doi-asserted-by":"publisher","unstructured":"M. Han, X. Cao, C. Zhao, L. Yang, N. Yin, P. Shen, J. Zhang, F. Gao, Y. Ren, D. Liang, J. Yang, Y. Zhang, Y. Liu, Assessment of glycometabolism impairment and glucose variability using flash glucose monitoring system in patients with adrenal diseases. Front. Endocrinol. 11(759), 544752 (2020). https:\/\/doi.org\/10.3389\/fendo.2020.544752","DOI":"10.3389\/fendo.2020.544752"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02576-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02576-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02576-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T15:23:05Z","timestamp":1619796185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02576-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2576"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02576-y","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]},"assertion":[{"value":"18 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}